ArticleCurrent oncology (Toronto, Ont.)2012

Cost-effectiveness of zoledronic acid compared with clodronate in multiple myeloma.

T E Delea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.